EYECHEQ INC. — SEC Form D Filing

EYECHEQ INC. filed an SEC Form D on June 25, 2026, reporting $9.95M raised in Health Technology.

Form D filing details

Filing
SEC Form D
Filing date
June 25, 2026
Amount reported
$9.95M
Industry
Health Technology
Website
https://www.eyecheq.com/

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

A significant number of patients, particularly those with diabetes, are not receiving the necessary diabetic retinopathy evaluations, leading to a risk of preventable blindness. This lack of evaluation contributes to care gaps for health plans and healthcare providers.

Solution

EyeCheq provides an intuitive screening kiosk that performs diabetic retinopathy screenings and other visual assessments. Retinal pictures are reviewed by an EyeCheq doctor to detect signs of health conditions like diabetes and high blood pressure.

Why now

There is a significant unmet need for accessible and convenient diabetic retinopathy screenings and general eye health assessments, especially with a large population at risk for preventable blindness and health issues. Technology allows for automated, easy-to-deploy screening solutions.

Verdict

This cleared because it presented a practical, deployable solution to an established healthcare gap, not because it promised novel medical breakthroughs. Investors implicitly bet on the operational efficiency gains and cost savings for health plans and providers by decentralizing a critical, but often missed, screening. Upside was limited by the specialized nature of diabetic retinopathy screening, constraining the potential for broad, general diagnostic application beyond its core focus.

Source: SEC EDGAR Form D filing